Laupacis A. Evidence and Values: Requirements for Public Reimbursement of Drugs for Rare Diseases- A Case Study in Oncology- Reply. J Popl Ther Clin Pharmacol. 2018;16(2). Accessed October 10, 2025. https://www.jptcp.com/index.php/jptcp/article/view/557